HIV pathology data now reaching investigators within hours

Established in 1994 and funded by the National Institutes of Health and National Cancer Institution has opted to use Proscia’s Concentriq for Research, a provider of digital and computational pathology solutions to encourage scientific exploration and discovery in cancer as well as PLWH. 

The ACSR says its mission is to ‘acquire, store, and equitably distribute biospecimens, including tissue-based pathology data, and associated clinical data from PLWH to the scientific community at large’.

The data has been used by investigators to drive the development of new diagnostic and treatment approaches for HIV-associated malignancies. As digital pathology shifts the standard from microscopes to high-resolution images, the ACSR recognized an opportunity to improve access to its data and drive further breakthroughs by adopting the technology.

Fight against cancer

“We are fortunate to have a growing library of rare and valuable biospecimens that have contributed to the fight against cancer in PLWH,” said Paige Bracci, UCSF professor of epidemiology and biostatistics, and director of the ACSR’s informatics program.

“Concentriq for Research has enabled us to quickly realize the benefits of digital pathology and get this real-world data in the hands of more researchers faster. Proscia’s platform is not only making a difference for the scientific community but also for the patients impacted by its work.”

Since selecting the software, the ACSR has reduced the time it takes to provide investigators with pathology data from days to hours. As the pathology platform enables the sharing of images instead of glass slides, the ACSR can overcome geographical barriers and simultaneously share the same datasets so that more research teams can drive scientific advancements.